dr. bekaii-saab on the impact of regorafenib in crc
Published 6 years ago • 70 plays • Length 2:26Download video MP4
Download video MP3
Similar videos
-
1:39
dr. bekaii-saab on dosing strategies with regorafenib in crc
-
0:57
dr. bekaii-saab discusses the next steps with regorafenib in crc
-
1:20
dr. bekaii-saab on the use of regorafenib in patients with mcrc
-
2:22
dr. bekaii-saab on differences between regorafenib and tas-102 in crc
-
1:50
dr. bekaii-saab on sequencing regorafenib and tas-102 in crc
-
1:16
dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
0:20
copy of dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
2:06
dr. bekaii-saab on the impact of the beacon crc study in braf-mutated crc
-
1:23
dr. bekaii-saab on benefits associated with regorafenib or tas-102 for crc
-
0:56
dr. bekaii-saab on tolerability of encorafenib, binimetinib, and cetuximab in braf crc
-
2:24
dr. bekaii saab compares toxicities of regorafenib and tas-102 in colorectal cancer
-
1:21
dr. bekaii-saab discusses regorafenib use in mcrc
-
1:33
dr. bekaii saab on the expansion of treatment options in colorectal cancer
-
1:12
tanios bekaii-saab, md: mechanisms of action in regorafenib
-
2:04
dr. bekaii saab on the role of immunotherapy in crc
-
2:27
dr. bekaii-saab on the redos study in metastatic colorectal cancer
-
1:45
dr. bekaii-saab on moving metastatic treatment strategies to the adjuvant setting in crc
-
9:34
regorafenib in colorectal cancer
-
1:16
dr. eng on roles of regorafenib and tas-102 in crc treatment